CPAP therapy improves golf performance in men with sleep apnea

December 13, 2013

DARIEN, IL - A new study suggests that treating obstructive sleep apnea (OSA) with continuous positive airway pressure (CPAP) therapy improves golf performance in middle-aged men.

Results show that up to six months of treatment with CPAP therapy was associated with significant improvements in self-reported excessive daytime sleepiness and sleep-related quality of life. Participants treated with CPAP therapy also experienced a significant drop of 11 percent in their average handicap index, a standardized formula that estimates a golfer's skill level. Among the more skilled golfers who had a baseline handicap index of 12 or less, the average handicap index dropped by 31.5 percent. Participants attributed their enhanced performance to factors such as improved concentration, endurance and decision making.

"The degree of improvement was most substantial in the better golfers who have done a superior job of managing the technical and mechanical aspects of golf," said principal investigator and lead author Dr. Marc Benton, senior partner at Atlantic Sleep & Pulmonary Associates and medical director of SleepWell Centers of NJ in Madison, N.J. "With the cognitive enhancement afforded by successful treatment of their sleep apnea, they saw measurable improvement early and more significantly than those who were less skilled."

The study results appear in the Dec. 15 issue of the Journal of Clinical Sleep Medicine, which is published by the American Academy of Sleep Medicine.

Objective data reporting shows that average utilization of CPAP therapy by participants in the treatment group was 6.3 hours per night for 91.4 percent of the nights, which is a much higher compliance rate than is typically reported. The results suggest that the potential for improved golf performance may have played a motivational role in increasing treatment compliance.

"An important aspect of providing high quality, patient-centered care is to identify the unique factors that motivate individual patients to comply with treatment," said American Academy of Sleep Medicine President Dr. M. Safwan Badr. "Effectively treating sleep apnea with CPAP therapy can yield numerous physical, cognitive and emotional benefits, all of which can be great motivators for patients when they begin treatment."

Benton and colleague Neil Friedman studied 12 men with moderate to severe obstructive sleep apnea who had a mean age of 55 years. A control group comprised 12 men without sleep apnea who were matched for age and handicap index. Participants had to maintain a handicap with the Golf Handicap and Information Network (GHIN), which is a service of the Unites States Golf Association (USGA). Their handicap index was recalculated after completion of 20 rounds of golf during the study period.

According to the authors, most avid golfers in the U.S. are adult males between 40 and 70 years of age, which is a demographic that has a high prevalence of obstructive sleep apnea. The AASM reports that OSA is a common sleep illness affecting up to seven percent of men and five percent of women. It involves repetitive episodes of complete or partial upper airway obstruction occurring during sleep despite an ongoing effort to breathe. The most effective treatment option for OSA is CPAP therapy, which helps keep the airway open by providing a stream of air through a mask that is worn during sleep.
-end-
The monthly, peer-reviewed Journal of Clinical Sleep Medicine is the official publication of the American Academy of Sleep Medicine, a professional membership society that improves sleep health and promotes high quality patient centered care through advocacy, education, strategic research, and practice standards (http://www.aasmnet.org). The AASM encourages patients to talk to their doctor about sleep problems or visit http://www.sleepeducation.com for a searchable directory of accredited sleep centers.

American Academy of Sleep Medicine

Related Sleep Apnea Articles from Brightsurf:

Sleep apnea may be risk factor for COVID-19
The question of sleep apnea as the risk factor for COVID-19 arose in a study conducted by the Turku University Hospital and the University of Turku on patients of the first wave of the pandemic.

Untreated sleep apnea is associated with flu hospitalization
As we approach flu season, adults with obstructive sleep apnea may want to take extra precautions.

Losing tongue fat improves sleep apnea
Using magnetic resonance imaging (MRI) to measure the effect of weight loss on the upper airway in obese patients, researchers found that reducing tongue fat is a primary factor in lessening the severity of OSA.

More cancer cases among women with sleep apnea
Women with severe sleep apnea appear to be at an elevated risk of getting cancer, a study shows.

New evidence on the association of shortened sleep time and obstructive sleep apnea with sleepiness and cardiometabolic risk factors
A new study in the journal CHEST® may change the way we think about sleep disorders.

Synthetic cannabis-like drug reduces sleep apnea
A synthetic cannabis-like drug in a pill reduced apnea and daytime sleepiness in the first large multi-site study of a drug for apnea.

Inflammation may precede sleep apnea, could be treatment target
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

Concerns that sleep apnea could impact healthspan
The number of people with obstructive sleep apnea has steadily increased over the past two decades.

Sleep apnea and insomnia combination linked with depression
A new study found that men with sleep apnea and insomnia have a higher prevalence and severity of depressive symptoms than men with sleep apnea or insomnia alone.

Anti-nausea drug could help treat sleep apnea
An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented today by University of Illinois at Chicago and Northwestern University scientists at the SLEEP 2017 annual meeting in Boston.

Read More: Sleep Apnea News and Sleep Apnea Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.